This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

*** Editor’s Pick

CHMP recommends Enhertu for HER2-low breast cancer treatment
CHMP recommends Enhertu for HER2-low breast cancer treatment
Significant placebo response to pain in cannabinoid clinical trials
Significant placebo response to pain in cannabinoid clinical trials
Elranatamab induces durable clinical response in relapsed multiple myeloma
Elranatamab induces durable clinical response in relapsed multiple myeloma
Review suggests GLP1 agonists offer similar glycaemic control to bariatric surgery
Review suggests GLP1 agonists offer similar glycaemic control to bariatric surgery
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Cannabidiol of no additional value for symptom distress reduction in advanced cancer
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Zanubrutinib improves progression-free survival in relapsed lymphocytic leukaemia
Aprocitentan superior to placebo in resistant hypertension
Aprocitentan superior to placebo in resistant hypertension
Highly purified EPA reduces adverse cardiovascular events in at-risk patients
Highly purified EPA reduces adverse cardiovascular events in at-risk patients
PCSK9 inhibitor persistence in FH high in clinical practice
PCSK9 inhibitor persistence in FH high in clinical practice
AI model predicts CVD risk from single chest radiograph
AI model predicts CVD risk from single chest radiograph
Higher liver stiffness persists several months after COVID-19 infection
Higher liver stiffness persists several months after COVID-19 infection
Enlarged perivascular spaces revealed by MRI in migraine sufferers
Enlarged perivascular spaces revealed by MRI in migraine sufferers


Popular articles

Aggressive end-of-life care more common in nursing home compared to community residents
Higher plasma caffeine levels linked to reduced body fat and type 2 diabetes risk according to genetic study
Shorter tuberculosis treatment strategy non-inferior to standard regimen
Prostate cancer mortality no different in trial of three treatment interventions
High-sensitivity CRP superior to LDL cholesterol for CV event and mortality risk prediction




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora